Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2007, Article ID 36150, 7 pages
http://dx.doi.org/10.1155/2007/36150
Review Article

A Role for Excitatory Amino Acids in Diabetic Eye Disease

1Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, USA
2Division of Ophthalmology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
3Department of Chemistry, The University of Illinois at Chicago, Chicago, IL 60607, USA

Received 28 February 2007; Accepted 19 March 2007

Academic Editor: Subrata Chakrabarti

Copyright © 2007 Jose E. Pulido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Diabetes Fact Sheet: United States 2005. Center for Disease Control. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf.
  2. J. H. Kempen, B. J. O'Colmain, M. C. Leske et al., “The prevalence of diabetic retinopathy among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 552–563, 2004. View at Publisher · View at Google Scholar
  3. R. Varma and M. Torres, “Prevalence of lens opacities in Latinos: the Los Angeles Latino eye study,” Ophthalmology, vol. 111, no. 8, pp. 1449–1456, 2004. View at Publisher · View at Google Scholar
  4. S. M. Marshall and A. Flyvbjerg, “Prevention and early detection of vascular complications of diabetes,” British Medical Journal, vol. 333, no. 7566, pp. 475–480, 2006. View at Publisher · View at Google Scholar
  5. S. M. Malinowski, J. S. Pulido, and R. R. Flickinger, “The protective effect of the tilted disc syndrome in diabetic retinopathy,” Archives of Ophthalmology, vol. 114, no. 2, pp. 230–231, 1996. View at Google Scholar
  6. S. Dev, J. S. Pulido, H. H. Tessler et al., “Progression of diabetic retinopathy after endophthalmitis,” Ophthalmology, vol. 106, no. 4, pp. 774–781, 1999. View at Publisher · View at Google Scholar
  7. J. S. Pulido, Retina, Choroid, and Vitreous, Mosby, St. Louis, Mo, USA, 2002.
  8. M. Cusick, E. Y. Chew, C.-C. Chan, H. S. Kruth, R. P. Murphy, and F. L. Ferris III, “Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels,” Ophthalmology, vol. 110, no. 11, pp. 2126–2133, 2003. View at Publisher · View at Google Scholar
  9. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar
  10. S. M. Brown and L. M. Jampol, “New concepts of regulation of retinal vessel tone,” Archives of Ophthalmology, vol. 114, no. 2, pp. 199–204, 1996. View at Google Scholar
  11. N. Izumi, T. Nagaoka, F. Mori, E. Sato, A. Takahashi, and A. Yoshida, “Relation between plasma nitric oxide levels and diabetic retinopathy,” Japanese Journal of Ophthalmology, vol. 50, no. 5, pp. 465–468, 2006. View at Publisher · View at Google Scholar
  12. E. A. Milusheva, V. I. Kuneva, D. E. Itzev, N. I. Kortezova, B. Sperlagh, and Z. N. Mizhorkova, “Glutamate stimulation of acetylcholine release from myenteric plexus is mediated by endogenous nitric oxide,” Brain Research Bulletin, vol. 66, no. 3, pp. 229–234, 2005. View at Publisher · View at Google Scholar
  13. T. K. Shires, J. A. Faeth, and J. S. Pulido, “Protein levels in the vitreous of rats with streptozotocin-induced diabetes mellitus,” Brain Research Bulletin, vol. 30, no. 1-2, pp. 85–90, 1993. View at Publisher · View at Google Scholar
  14. M. Ouchi, K. West, J. W. Crabb, S. Kinoshita, and M. Kamei, “Proteomic analysis of vitreous from diabetic macular edema,” Experimental Eye Research, vol. 81, no. 2, pp. 176–182, 2005. View at Publisher · View at Google Scholar
  15. J. Sebag, S. Nie, K. Reiser, M. A. Charles, and N.-T. Yu, “Raman spectroscopy of human vitreous in proliferative diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 35, no. 7, pp. 2976–2980, 1994. View at Google Scholar
  16. T. K. Shires, J. A. Faeth, and J. S. Pulido, “Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat,” Retina, vol. 10, no. 2, pp. 153–158, 1990. View at Publisher · View at Google Scholar
  17. J. S. Pulido, “Experimental nonenzymatic glycosylation of vitreous collagens occurs by two patients,” Transactions of the American Ophthalmological Society, vol. 94, pp. 1029–1072, 1996. View at Google Scholar
  18. R. Werman, “Amino acids as central neurotransmitters,” Research Publications - Association for Research in Nervous and Mental Disease, vol. 50, pp. 147–180, 1972. View at Google Scholar
  19. J. W. Olney, “Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion,” Journal of Neuropathology and Experimental Neurology, vol. 28, no. 3, pp. 455–474, 1969. View at Google Scholar
  20. J. W. Olney and O. L. Ho, “Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine,” Nature, vol. 227, no. 5258, pp. 609–611, 1970. View at Publisher · View at Google Scholar
  21. S. H. DeVries, “Bipolar cells use kainate and AMPA receptors to filter visual information into separate channels,” Neuron, vol. 28, no. 3, pp. 847–856, 2000. View at Publisher · View at Google Scholar
  22. J. L. Arriza, S. Eliasof, M. P. Kavanaugh, and S. G. Amara, “Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 4155–4160, 1997. View at Publisher · View at Google Scholar
  23. W. A. Fairman, R. J. Vandenberg, J. L. Arriza, M. P. Kavanaugh, and S. G. Amara, “An excitatory amino-acid transporter with properties of a ligand-gated chloride channel,” Nature, vol. 375, no. 6532, pp. 599–603, 1995. View at Publisher · View at Google Scholar
  24. Y. Kanai and M. A. Hediger, “Primary structure and functional characterization of a high-affinity glutamate transporter,” Nature, vol. 360, no. 6403, pp. 467–471, 1992. View at Publisher · View at Google Scholar
  25. G. Pines, N. C. Danbolt, M. Bjoras et al., “Cloning and expression of a rat brain L-glutamate transporter,” Nature, vol. 360, no. 6403, pp. 464–467, 1992. View at Publisher · View at Google Scholar
  26. T. Storck, S. Schulte, K. Hofmann, and W. Stoffel, “Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 22, pp. 10955–10959, 1992. View at Publisher · View at Google Scholar
  27. S. A. Lipton, “The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism,” Current Alzheimer Research, vol. 2, no. 2, pp. 155–165, 2005. View at Publisher · View at Google Scholar
  28. J. Vaquero and R. F. Butterworth, “The brain glutamate system in liver failure,” Journal of Neurochemistry, vol. 98, no. 3, pp. 661–669, 2006. View at Publisher · View at Google Scholar
  29. M. Yoshioka, W. G. Bradley, P. Shapshak et al., “Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases,” Advances in Neuroimmunology, vol. 5, no. 3, pp. 335–358, 1995. View at Publisher · View at Google Scholar
  30. S. J. Won, D. Y. Kim, and B. J. Gwag, “Cellular and molecular pathways of ischemic neuronal death,” Journal of Biochemistry and Molecular Biology, vol. 35, no. 1, pp. 67–86, 2002. View at Google Scholar
  31. G. L. Wenk, “Neuropathologic changes in Alzheimer's disease: potential targets for treatment,” Journal of Clinical Psychiatry, vol. 67, 3, pp. 3–7, 2006. View at Google Scholar
  32. D.-M. Chuang, “Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?” Critical Reviews in Neurobiology, vol. 16, no. 1-2, pp. 83–90, 2004. View at Publisher · View at Google Scholar
  33. M. H. Kuehn, J. H. Fingert, and Y. H. Kwon, “Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies,” Ophthalmology Clinics of North America, vol. 18, no. 3, pp. 383–395, 2005. View at Publisher · View at Google Scholar
  34. E. Lieth, A. J. Barber, B. Xu et al., “Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy,” Diabetes, vol. 47, no. 5, pp. 815–820, 1998. View at Publisher · View at Google Scholar
  35. R. S. Mali, M. Cheng, and S. K. Chintala, “Plasminogen activators promote excitotoxicity-induced retinal damage,” FASEB Journal, vol. 19, no. 10, pp. 1280–1289, 2005. View at Publisher · View at Google Scholar
  36. T. Kunimatsu, S. Asai, K. Kanematsu, T. Kohno, T. Misaki, and K. Ishikawa, “Effects of glutamate receptor agonist on extracellular glutamate dynamics during moderate cerebral ischemia,” Brain Research, vol. 923, no. 1-2, pp. 178–186, 2001. View at Publisher · View at Google Scholar
  37. R. C. Tasker, J. T. Coyle, and J. J. Vornov, “The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801,” The Journal of Neuroscience, vol. 12, no. 11, pp. 4298–4308, 1992. View at Google Scholar
  38. L. Massieu, N. Gómez-Román, and T. Montiel, “In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate,” Experimental Neurology, vol. 165, no. 2, pp. 257–267, 2000. View at Publisher · View at Google Scholar
  39. E. B. Dreyer, D. Zhang, and S. A. Lipton, “Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death,” NeuroReport, vol. 6, no. 6, pp. 942–944, 1995. View at Google Scholar
  40. J. Ambati, K. V. Chalam, D. K. Chawala et al., “Elevated ?-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 115, no. 9, pp. 1161–1166, 1997. View at Google Scholar
  41. R. M. H. Diederen, E. C. La Heij, N. E. P. Deutz et al., “Increased glutamate levels in the vitreous of patients with retinal detachment,” Experimental Eye Research, vol. 83, no. 1, pp. 45–50, 2006. View at Publisher · View at Google Scholar
  42. E. B. Dreyer, D. Zurakowski, R. A. Schumer, S. M. Podos, and S. A. Lipton, “Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma,” Archives of Ophthalmology, vol. 114, no. 3, pp. 299–305, 1996. View at Google Scholar
  43. A. Derouiche and T. Rauen, “Coincidence of L-glutamate/L-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance,” Journal of Neuroscience Research, vol. 42, no. 1, pp. 131–143, 1995. View at Publisher · View at Google Scholar
  44. T. Rauen and B. I. Kanner, “Localization of the glutamate transporter GLT-1 in rat and macaque monkey retinae,” Neuroscience Letters, vol. 169, no. 1-2, pp. 137–140, 1994. View at Publisher · View at Google Scholar
  45. M. Wiessner, E. L. Fletcher, F. Fischer, and T. Rauen, “Localization and possible function of the glutamate transporter, EAAC1, in the rat retina,” Cell and Tissue Research, vol. 310, no. 1, pp. 31–40, 2002. View at Publisher · View at Google Scholar
  46. D. V. Pow and N. L. Barnett, “Developmental expression of excitatory amino acid transporter 5: a photoreceptor and bipolar cell glutamate transporter in rat retina,” Neuroscience Letters, vol. 280, no. 1, pp. 21–24, 2000. View at Publisher · View at Google Scholar
  47. T. Rauen, W. R. Taylor, K. Kuhlbrodt, and M. Wiessner, “High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance,” Cell and Tissue Research, vol. 291, no. 1, pp. 19–31, 1998. View at Publisher · View at Google Scholar
  48. L. T. Macnab, S. M. Williams, and D. V. Pow, “Expression of the exon 3 skipping form of GLAST, GLAST1a, in brain and retina,” NeuroReport, vol. 17, no. 18, pp. 1867–1870, 2006. View at Publisher · View at Google Scholar
  49. U. Grünert, B. Lin, and P. R. Martin, “Glutamate receptors at bipolar synapses in the inner plexiform layer of primate retina: light microscopic analysis,” Journal of Comparative Neurology, vol. 466, no. 1, pp. 136–147, 2003. View at Google Scholar
  50. F. Pan and S. C. Massey, “Rod and cone input to horizontal cells in the rabbit retina,” Journal of Comparative Neurology, vol. 500, no. 5, pp. 815–831, 2007. View at Publisher · View at Google Scholar
  51. R. C. Rentería, N. Tian, J. Cang, S. Nakanishi, M. P. Stryker, and D. R. Copenhagen, “Intrinsic ON responses of the retinal OFF pathway are suppressed by the ON pathway,” The Journal of Neuroscience, vol. 26, no. 46, pp. 11857–11869, 2006. View at Publisher · View at Google Scholar
  52. R. J. Jensen, “Activation of group II metabotropic glutamate receptors reduces directional selectivity in retinal ganglion cells,” Brain Research, vol. 1122, no. 1, pp. 86–92, 2006. View at Publisher · View at Google Scholar
  53. T. M. Skerry and P. G. Genever, “Glutamate signalling in non-neuronal tissues,” Trends in Pharmacological Sciences, vol. 22, no. 4, pp. 174–181, 2001. View at Publisher · View at Google Scholar
  54. C. Mawrin, T. Pap, M. Pallas, K. Dietzmann, W. Behrens-Baumann, and C. K. Vorwerk, “Changes of retinal glutamate transporter GLT-1 mRNA levels following optic nerve damage,” Molecular Vision, vol. 9, pp. 10–13, 2003. View at Google Scholar
  55. L. Guo, T. E. Salt, A. Maass et al., “Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo,” Investigative Ophthalmology and Visual Science, vol. 47, no. 2, pp. 626–633, 2006. View at Publisher · View at Google Scholar
  56. K. R. Martin, H. Levkovitch-Verbin, D. Valenta, L. Baumrind, M. E. Pease, and H. A. Quigley, “Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2236–2243, 2002. View at Google Scholar
  57. R. Naskar, C. K. Vorwerk, and E. B. Dreyer, “Concurrent downregulation of a glutamate transporter and receptor in glaucoma,” Investigative Ophthalmology and Visual Science, vol. 41, no. 7, pp. 1940–1944, 2000. View at Google Scholar
  58. R. A. Honkanen, S. Baruah, M. B. Zimmerman et al., “Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy,” Archives of Ophthalmology, vol. 121, no. 2, pp. 183–188, 2003. View at Google Scholar
  59. R. M. H. Diederen, E. C. La Heij, N. E. P. Deutz et al., “Increased glutamate levels in the vitreous of patients with retinal detachment,” Experimental Eye Research, vol. 83, no. 1, pp. 45–50, 2006. View at Publisher · View at Google Scholar
  60. J. Deng, D. Z. Wu, and R. Gao, “Detection of glutamate and γ-aminobutyric acid in vitreous of patients with proliferative diabetic retinopathy,” Yan Ke Xue Bao, vol. 16, no. 3, pp. 199–202, 2000. View at Google Scholar
  61. V. M. Asensio Sanchez, A. A. Corral, A. B. Aragón, and G. M. De Paz, “Sarcoidosis of the optic nerve,” Archivos de la Sociedad Espanola de Oftalmologia, vol. 78, no. 3, pp. 165–168, 2003. View at Google Scholar
  62. I. G. Obrosova, V. R. Drel, A. K. Kumagai, C. Szábo, P. Pacher, and M. J. Stevens, “Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models,” Diabetologia, vol. 49, no. 10, pp. 2525–2533, 2006. View at Publisher · View at Google Scholar
  63. M. M. Ward, A. I. Jobling, M. Kalloniatis, and E. L. Fletcher, “Glutamate uptake in retinal glial cells during diabetes,” Diabetologia, vol. 48, no. 2, pp. 351–360, 2005. View at Publisher · View at Google Scholar
  64. D. G. Puro, “Diabetes-induced dysfunction of retinal Müller cells,” Transactions of the American Ophthalmological Society, vol. 100, pp. 339–352, 2002. View at Google Scholar
  65. R. A. Kowluru, R. L. Engerman, G. L. Case, and T. S. Kerns, “Retinal glutamate in diabetes and effect of antioxidants,” Neurochemistry International, vol. 38, no. 5, pp. 385–390, 2001. View at Publisher · View at Google Scholar
  66. N. L. Barnett, D. V. Pow, and N. D. Bull, “Differential perturbation of neuronal and glial glutamate transport systems in retinal ischaemia,” Neurochemistry International, vol. 39, no. 4, pp. 291–299, 2001. View at Publisher · View at Google Scholar
  67. A. R. Santiago, S. C. Rosa, P. F. Santos, A. J. Cristóvão, A. J. Barber, and A. F. Ambrósio, “Elevated glucose changes the expression of ionotropic glutamate receptor subunits and impairs calcium homeostasis in retinal neural cells,” Investigative Ophthalmology & Visual Science, vol. 47, no. 9, pp. 4130–4137, 2006. View at Publisher · View at Google Scholar
  68. L. Gao, J. S. Pulido, R. M. Hatfield, R. F. Dundervill III, C. A. McCannel, and S. Shippy, “Capillary electrophoretic assay for nitrate levels in the vitreous of proliferative diabetic retinopathy,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 847, no. 2, pp. 300–304, 2007. View at Publisher · View at Google Scholar
  69. S. Koponen, K. Kurkinen, K. E. O. Åkerman, D. Mochly-Rosen, P. H. Chan, and J. Koistinaho, “Prevention of NMDA-induced death of cortical neurons by inhibition of protein kinase Cζ,” Journal of Neurochemistry, vol. 86, no. 2, pp. 442–450, 2003. View at Publisher · View at Google Scholar
  70. M. Neid, K. Datta, S. Stephan et al., “Role of insulin receptor substrates and protein kinase C-? in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 3941–3948, 2004. View at Publisher · View at Google Scholar